Enanta Pharmaceuticals (ENTA) Tax Provisions (2016 - 2025)
Historic Tax Provisions for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Q3 2025 value amounting to -$80000.0.
- Enanta Pharmaceuticals' Tax Provisions rose 8561.15% to -$80000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 847.11%. This contributed to the annual value of -$1.8 million for FY2025, which is 847.11% up from last year.
- Latest data reveals that Enanta Pharmaceuticals reported Tax Provisions of -$80000.0 as of Q3 2025, which was up 8561.15% from $29000.0 recorded in Q2 2025.
- Over the past 5 years, Enanta Pharmaceuticals' Tax Provisions peaked at $7.1 million during Q1 2021, and registered a low of -$9.4 million during Q2 2021.
- For the 5-year period, Enanta Pharmaceuticals' Tax Provisions averaged around -$698833.3, with its median value being -$379000.0 (2024).
- Examining YoY changes over the last 5 years, Enanta Pharmaceuticals' Tax Provisions showed a top increase of 104429.53% in 2023 and a maximum decrease of 7040000.0% in 2023.
- Enanta Pharmaceuticals' Tax Provisions (Quarter) stood at -$36000.0 in 2021, then rose by 5.56% to -$34000.0 in 2022, then tumbled by 1729.41% to -$622000.0 in 2023, then skyrocketed by 33.12% to -$416000.0 in 2024, then soared by 80.77% to -$80000.0 in 2025.
- Its last three reported values are -$80000.0 in Q3 2025, $29000.0 for Q2 2025, and -$1.3 million during Q1 2025.